Word

ROIVANT FOUNDATION

Status

Registered

Status Code

700

Status Date

Tuesday, May 31, 2022

Serial Number

90452438

Registration Number

6742376

Registration Date

Tuesday, May 31, 2022

Mark Type

4000

Filing Date

Thursday, January 7, 2021

Published for Opposition

Tuesday, March 15, 2022

Trademark Owner History

Roivant Sciences GmbH - Original Registrant

Classifications

5 Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; biologic preparations for medical and therapeutic purposes for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions

36 Charitable fundraising services

44 Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

42 Scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials

"FOUNDATION"

Trademark Events

May 31, 2022

Notice Of Registration Confirmation Emailed

May 31, 2022

Registered-Principal Register

Mar 15, 2022

Official Gazette Publication Confirmation E-Mailed

Mar 15, 2022

Published For Opposition

Feb 23, 2022

Notification Of Notice Of Publication E-Mailed

Feb 10, 2022

Approved For Pub - Principal Register

Feb 10, 2022

Examiner's Amendment Entered

Feb 10, 2022

Notification Of Examiners Amendment E-Mailed

Feb 10, 2022

Examiners Amendment E-Mailed

Feb 10, 2022

Examiners Amendment -Written

Jan 10, 2022

Teas/Email Correspondence Entered

Jan 10, 2022

Correspondence Received In Law Office

Jan 10, 2022

Teas Response To Office Action Received

Sep 14, 2021

Assigned To Examiner

Jul 17, 2021

Notification Of Non-Final Action E-Mailed

Jul 17, 2021

Non-Final Action E-Mailed

Jul 17, 2021

Non-Final Action Written

Jul 16, 2021

Assigned To Examiner

Apr 6, 2021

New Application Office Supplied Data Entered In Tram

Jan 11, 2021

New Application Entered In Tram